Global Non-invasive Parenteral Screening Market Size, Status and Forecast 2019-2025

SKU ID : QYR- 13803726

Publishing Date : 14-Aug-2019

No. of pages : 99

PRICE
3900
7800

  • Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.
    In 2018, the global Non-invasive Parenteral Screening market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

    This report focuses on the global Non-invasive Parenteral Screening status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Non-invasive Parenteral Screening development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

    The key players covered in this study
    GE Healthcare
    Philips
    Illumina
    Thermo Fisher Scientific
    Roche
    PacBio
    Perkinelmer
    Qiagen
    Agilent Technologies
    BGI Group

    Market segment by Type, the product can be split into
    Instruments
    Consumables

    Market segment by Application, split into
    Diagnostic Laboratories
    Hospitals

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Non-invasive Parenteral Screening status, future forecast, growth opportunity, key market and key players.
    To present the Non-invasive Parenteral Screening development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by product type, market and key regions.

    In this study, the years considered to estimate the market size of Non-invasive Parenteral Screening are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025
    For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports